CVS Stock Rises Over 3% on Analyst Upgrades and Strong Earnings
On May 12, 2026, CVS Health (NYSE: CVS) stock surged over 3%, outperforming the broader market amid upgraded price targets from two analysts. J.P. Morgan's Lisa Gill raised her target to $111 per share and Lance Wilkes increased his to $106 per share, both maintaining buy recommendations following strong Q1 earnings.
Topics: analysts buy recommendations CVS Health price targets